Kobayashi Pharmaceutical Past Earnings Performance
Past criteria checks 0/6
Kobayashi Pharmaceutical's earnings have been declining at an average annual rate of -3.2%, while the Personal Products industry saw earnings growing at 3.8% annually. Revenues have been growing at an average rate of 1.7% per year. Kobayashi Pharmaceutical's return on equity is 5%, and it has net margins of 6%.
Key information
-3.2%
Earnings growth rate
-2.4%
EPS growth rate
Personal Products Industry Growth | 8.7% |
Revenue growth rate | 1.7% |
Return on equity | 5.0% |
Net Margin | 6.0% |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Kobayashi Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 168,799 | 10,184 | 54,624 | 9,004 |
30 Jun 24 | 172,966 | 13,910 | 56,817 | 9,004 |
31 Mar 24 | 176,473 | 17,706 | 59,271 | 9,004 |
31 Dec 23 | 173,455 | 20,338 | 57,611 | 9,004 |
30 Sep 23 | 171,094 | 21,020 | 56,165 | 8,327 |
30 Jun 23 | 168,619 | 20,186 | 55,090 | 8,327 |
31 Mar 23 | 167,079 | 20,157 | 54,537 | 8,327 |
31 Dec 22 | 166,258 | 20,022 | 54,065 | 8,327 |
30 Sep 22 | 161,873 | 19,332 | 54,856 | 7,522 |
30 Jun 22 | 159,464 | 19,534 | 53,879 | 7,522 |
31 Mar 22 | 157,629 | 19,560 | 52,891 | 7,522 |
31 Dec 21 | 155,252 | 19,715 | 52,188 | 7,522 |
30 Sep 21 | 153,123 | 18,830 | 52,491 | 7,338 |
30 Jun 21 | 151,386 | 18,868 | 51,429 | 7,338 |
31 Mar 21 | 148,872 | 19,091 | 50,006 | 7,338 |
31 Dec 20 | 150,514 | 19,205 | 50,249 | 7,338 |
30 Sep 20 | 155,312 | 19,152 | 55,393 | 7,110 |
30 Jun 20 | 160,602 | 19,155 | 60,695 | 7,110 |
31 Mar 20 | 166,228 | 19,198 | 65,381 | 7,110 |
31 Dec 19 | 168,052 | 19,139 | 67,997 | 7,110 |
30 Sep 19 | 169,500 | 19,259 | 68,935 | 7,031 |
30 Jun 19 | 168,431 | 18,596 | 68,950 | 7,031 |
31 Mar 19 | 167,499 | 17,885 | 68,409 | 7,031 |
31 Dec 18 | 167,479 | 18,023 | 68,119 | 7,031 |
30 Sep 18 | 164,876 | 18,132 | 66,762 | 7,239 |
30 Jun 18 | 162,132 | 16,455 | 66,070 | 7,239 |
31 Mar 18 | 159,727 | 16,229 | 64,906 | 7,239 |
31 Dec 17 | 156,761 | 15,863 | 63,540 | 7,239 |
31 Dec 16 | 152,654 | 15,333 | 58,018 | 9,909 |
30 Sep 16 | 148,008 | 15,561 | 59,206 | 5,788 |
30 Jun 16 | 144,007 | 15,801 | 56,081 | 5,788 |
31 Mar 16 | 137,211 | 13,466 | 54,121 | 5,788 |
31 Dec 15 | 135,798 | 14,230 | 51,882 | 5,289 |
30 Sep 15 | 133,385 | 13,008 | 50,362 | 5,289 |
30 Jun 15 | 131,144 | 12,915 | 49,227 | 5,289 |
31 Mar 15 | 128,344 | 12,448 | 48,963 | 5,289 |
31 Dec 14 | 128,721 | 12,730 | 49,511 | 4,930 |
30 Sep 14 | 127,574 | 11,808 | 49,610 | 4,930 |
30 Jun 14 | 127,256 | 11,760 | 49,421 | 4,930 |
31 Mar 14 | 127,293 | 12,307 | 48,662 | 4,930 |
31 Dec 13 | 122,430 | 10,819 | 47,374 | 4,544 |
Quality Earnings: KOY has a large one-off loss of ¥10.7B impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: KOY's current net profit margins (6%) are lower than last year (12.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: KOY's earnings have declined by 3.2% per year over the past 5 years.
Accelerating Growth: KOY's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: KOY had negative earnings growth (-51.6%) over the past year, making it difficult to compare to the Personal Products industry average (10.8%).
Return on Equity
High ROE: KOY's Return on Equity (5%) is considered low.